Identification and Characterization of Youth With Extreme Obesity

NCT01625325 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 429

Last updated 2018-06-13

No results posted yet for this study

Summary

While obese and extremely obese youth are at increased risk of health complications, especially the extremely obese group rarely seek medical care. One of the underlying reasons might be the lack of adequate treatment options. This study is a subproject of the "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care study", short: "Youth with Extreme obesity Study (YES)", which aims at improving the medical care and social support structures for youth with obesity and extreme obesity in Germany. In this subproject, information on the causes and consequences of extreme obesity will be gathered via questionnaires and medical examinations.

Obese youth and young adults (BMI ≥ 30kg/m2) between the ages of 14 and 24.9 years (initially up to 21 years) are eligible to participate. Participants will be asked to complete a series of questionnaires on their general health, psychosocial situation and wellbeing in 2-3 sessions. They will be offered a thorough medical examination comprising a general check-up, a fasting blood draw and oral glucose tolerance test, a focused orthopaedic examination, a sleep apnea screening, and an ultrasound of the liver. The aim of the study is to elicit the acceptance of diagnostic and therapeutic procedures, and to assess the frequency of co-morbidities in obese and extremely obese youth. This knowledge will optimize medical treatment and support options. Interested participants will be invited to participate in further steps of YES, which entail medical care and psycho-social support.

Conditions

Sponsors & Collaborators

  • University of Witten/Herdecke

    collaborator OTHER
  • Charite University, Berlin, Germany

    collaborator OTHER
  • University of Leipzig

    collaborator OTHER
  • Universität Duisburg-Essen

    collaborator OTHER
  • Prof. Dr. Martin Wabitsch

    lead OTHER

Principal Investigators

  • Martin Wabitsch, Prof. Dr. med. · University of Ulm

  • Susanna Wiegand, Dr. med. · Charite University, Berlin, Germany

  • Thomas Reinehr, Prof. Dr. med. · University of Witten/Herdecke

  • Johannes Hebebrand, Prof. Dr. med. · Universität Duisburg-Essen

  • Wieland Kiess, Prof. Dr. med. · University of Leipzig

  • Reinhard Holl, Prof. Dr. med. · University of Ulm

  • Anja Moss, Dr. biol. hum. · University of Ulm

  • Belinda S Lennerz, Dr. med. · University of Ulm

  • Julia von Schnurbein, Dr. med. · University of Ulm

Eligibility

Min Age
14 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-11-30
Completion
2014-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01625325 on ClinicalTrials.gov